# Intensity Modulated Radiation Therapy (IMRT) Pelvic Nodes Prostate

> **NCT00915122** · PHASE1,PHASE2 · COMPLETED · sponsor: **University Health Network, Toronto** · enrollment: 81 (actual)

## Conditions studied

- Adenocarcinoma of the Prostate

## Interventions

- **RADIATION:** Dose Escalated IMRT

## Key facts

- **NCT ID:** NCT00915122
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-11
- **Primary completion:** 2010-09
- **Final completion:** 2023-10-24
- **Target enrollment:** 81 (ACTUAL)
- **Last updated:** 2023-12-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00915122

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00915122, "Intensity Modulated Radiation Therapy (IMRT) Pelvic Nodes Prostate". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00915122. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*